Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone

Drug Metabolism and Disposition

Volumn 41, Issue 2, 2013, Pages 263-269

  Choi, Su Young ^a   Koh, Kwi Hye ^a   Jeong, Hyunyoung ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; DRUG METABOLIZING ENZYME; ESTRADIOL; MESSENGER RNA; PROGESTERONE;

ADULT; AGED; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LIVER CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY;

ADULT; AGED; BIOTRANSFORMATION; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; ESTRADIOL; FEMALE; HEPATOCYTES; HUMANS; ISOENZYMES; MIDDLE AGED; PREGNANCY; PRIMARY CELL CULTURE; PROGESTERONE; RNA, MESSENGER; SUBSTRATE SPECIFICITY; TIME FACTORS;

EID: 84872734709     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.046276     Document Type: Article

References (46)

1. Aguiar M, Masse R, and Gibbs BF (2005) Regulation of cytochrome P450 by posttranslational modification. Drug Metab Rev 37:379-404. (Pubitemid 40677509)
2. Anderson GD (2005a) Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44:989-1008. (Pubitemid 41356388)
3. Anderson GD (2005b) Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 14:19-29. (Pubitemid 40309363)
4. Anderson GD and Carr DB (2009) Effect of pregnancy on the pharmacokinetics of antihypertensive drugs. Clin Pharmacokinet 48:159-168.
5. Andrade SE, Gurwitz JH, and Davis RL, et al. (2004) Prescription drug use in pregnancy. Am J Obstet Gynecol 191:398-407. (Pubitemid 39178690)
6. Bandiera S and Dworschak C (1992) Effects of testosterone and estrogen on hepatic levels of cytochromes P450 2C7 and P450 2C11 in the rat. Arch Biochem Biophys 296:286- 295.
7. Burk O, Koch I, Raucy J, Hustert E, Eichelbaum M, Brockmöller J, Zanger UM, and Wojnowski L (2004) The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J Biol Chem 279:38379-38385. (Pubitemid 39295987)
8. Chen H, Yang K, Choi S, Fischer JH, and Jeong H (2009) Up-regulation of UDPglucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy. Drug Metab Dispos 37:1841-1847.
9. Choi S, Sainz B, Jr., Corcoran P, Uprichard S, and Jeong H (2009) Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells. Xenobiotica 39:205-217.
10. Choi SY, Fischer L, Yang K, Chung H, and Jeong H (2011) Isoform-specific regulation of cytochrome P450 expression and activity by estradiol in female rats. Biochem Pharmacol 81: 777-782.
11. Dannan GA, Guengerich FP, and Waxman DJ (1986) Hormonal regulation of rat liver microsomal enzymes: role of gonadal steroids in programming, maintenance, and suppression of d 4- steroid 5 a-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450. J Biol Chem 261:10728-10735. (Pubitemid 17194858)
12. Dean ME and Stock BH (1975) Hepatic microsomal metabolism of drugs during pregnancy in the rat. Drug Metab Dispos 3:325-331.
13. Dempsey D, Jacob P, 3rd, and Benowitz NL (2002) Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 301:594-598. (Pubitemid 34429972)
14. Dickins M (2004) Induction of cytochromes P450. Curr Top Med Chem 4:1745-1766. (Pubitemid 39654460)
15. Ferguson SS, Chen Y, LeCluyse EL, Negishi M, and Goldstein JA (2005) Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4a. Mol Pharmacol 68: 747-757. (Pubitemid 41206028)
16. Gerbal-Chaloin S, Daujat M, Pascussi JM, Pichard-Garcia L, Vilarem MJ, and Maurel P (2002) Transcriptional regulation of CYP2C9 gene: role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem 277:209-217. (Pubitemid 34952047)
17. Gerbal-Chaloin S, Pascussi JM, Pichard-Garcia L, Daujat M, Waechter F, Fabre JM, Carrère N, and Maurel P (2001) Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos 29:242-251. (Pubitemid 32179522)
18. Glover DD, Amonkar M, Rybeck BF, and Tracy TS (2003) Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 188:1039-1045. (Pubitemid 36530060)
19. Goldzieher JW and Brody SA (1990) Pharmacokinetics of ethinyl estradiol and mestranol. Am J Obstet Gynecol 163:2114-2119.
20. Hanioka N, Jinno H, Tanaka-Kagawa T, Nishimura T, and Ando M (2001) Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver microsomes by HPLC with UV detection. J Pharm Biomed Anal 25:65-75. (Pubitemid 32234400)
21. Higashi E, Fukami T, Itoh M, Kyo S, Inoue M, Yokoi T, and Nakajima M (2007) Human CYP2A6 is induced by estrogen via estrogen receptor. Drug Metab Dispos 35:1935-1941. (Pubitemid 47481589)
22. Hodge LS and Tracy TS (2007) Alterations in drug disposition during pregnancy: implications for drug therapy. Expert Opin Drug Metab Toxicol 3:557-571. (Pubitemid 351324964)
23. Jeong H, Choi S, Song JW, Chen H, and Fischer JH (2008) Regulation of UDPglucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination. Xenobiotica 38:62-75.
24. Kaminsky LS and Guengerich FP (1985) Cytochrome P-450 isozyme/isozyme functional interactions and NADPH-cytochrome P-450 reductase concentrations as factors in microsomal metabolism of warfarin. Eur J Biochem 149:479-489. (Pubitemid 15068152)
25. Koh KH, Jurkovic S, Yang K, Choi SY, Jung JW, Kim KP, Zhang W, and Jeong H (2012) Estradiol induces cytochrome P450 2B6 expression at high concentrations: implication in estrogen-mediated gene regulation in pregnancy. Biochem Pharmacol 84:93-103.
26. Kuhl H (1990) Pharmacokinetics of oestrogens and progestogens. Maturitas 12:171-197. (Pubitemid 20279929)
27. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, and Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016-1023. (Pubitemid 28419246)
28. Lo R, Burgoon L, Macpherson L, Ahmed S, and Matthews J (2010) Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells. Biochim Biophys Acta 1799:469-479.
29. Maglich JM, Parks DJ, and Moore LB, et al. (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278:17277-17283. (Pubitemid 36799610)
30. Masuyama H, Hiramatsu Y, Kodama J, and Kudo T (2003) Expression and potential roles of pregnane X receptor in endometrial cancer. J Clin Endocrinol Metab 88:4446-4454. (Pubitemid 37153756)
31. Mathur RS, Landgrebe S, and Williamson HO (1980) Progesterone, 17-hydroxyprogesterone, estradiol, and estriol in late pregnancy and labor. Am J Obstet Gynecol 136:25-27. (Pubitemid 10160057)
32. Mwinyi J, Cavaco I, Pedersen RS, Persson A, Burkhardt S, Mkrtchian S, and Ingelman-Sundberg M (2010) Regulation of CYP2C19 expression by estrogen receptor a: implications for estrogen-dependent inhibition of drug metabolism. Mol Pharmacol 78:886-894.
33. Ochs H, Düsterberg B, and Schulte-Hermann R (1986) Induction of monooxygenases and growth in rat liver by progesterone. Arch Toxicol 59:146-149. (Pubitemid 17040691)
34. Rae JM, Johnson MD, Lippman ME, and Flockhart DA (2001) Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J Pharmacol Exp Ther 299:849-857. (Pubitemid 33104951)
35. Revelli A, Massobrio M, and Tesarik J (1998) Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev 19:3-17. (Pubitemid 29122072)
36. Roberts BJ, Song BJ, Soh Y, Park SS, and Shoaf SE (1995) Ethanol induces CYP2E1 by protein stabilization: role of ubiquitin conjugation in the rapid degradation of CYP2E1. J Biol Chem 270:29632-29635.
37. Stricker R, Eberhart R, Chevailler MC, Quinn FA, Bischof P, and Stricker R (2006) Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clin Chem Lab Med 44:883-887.
38. Stumpf WE (1969) Nuclear concentration of 3H-estradiol in target tissues: dry-mount autoradiography of vagina, oviduct, ovary, testis, mammary tumor, liver and adrenal. Endocrinology 85:31-37.
39. Totah RA and Rettie AE (2005) Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance. Clin Pharmacol Ther 77:341-352. (Pubitemid 40719263)
40. Tulchinsky D, Hobel CJ, Yeager E, and Marshall JR (1972) Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol 112:1095-1100.
41. Wang H and Strobel HW (1997) Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch Biochem Biophys 344:365-372. (Pubitemid 27344074)
42. Waxman DJ, Dannan GA, and Guengerich FP (1985) Regulation of rat hepatic cytochrome P- 450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sexspecific isoenzymes. Biochemistry 24:4409-4417. (Pubitemid 15228447)
43. Waxman DJ and Holloway MG (2009) Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76:215-228.
44. Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, Hamman MA, Hall SD, and Wrighton SA (2002) Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos 30:883-891. (Pubitemid 34815417)
45. Wortham M, Czerwinski M, He L, Parkinson A, and Wan YJ (2007) Expression of constitutive androstane receptor, hepatic nuclear factor 4a, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos 35:1700-1710. (Pubitemid 47296067)
46. Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dréano Y, Menard C, Picart D, and Berthou F (1997) Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of pnitrophenol, a catalytic activity known to be specific for P450 2E1. Chem Res Toxicol 10: 1205-1212. (Pubitemid 27449526)